Medicus Pharma (MDCX) Total Current Liabilities (2023 - 2025)
Medicus Pharma (MDCX) posted Total Current Liabilities of $9.9 million for Q4 2025, down 6.75% quarter-over-quarter from $10.7 million in Q3 2025, and up 330.92% year-on-year from $2.3 million in Q4 2024.
Medicus Pharma (MDCX) Total Current Liabilities (2023 - 2025) Analysis & Trends
Medicus Pharma (MDCX) has reported Total Current Liabilities for 3 consecutive years, with $9.9 million the latest figure, recorded in Q4 2025.
- Total Current Liabilities for Q4 2025 came in at $9.9 million, up 330.92% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.9 million (up 330.92% YoY), and the FY2025 annual result was $9.9 million, up 330.92% from the prior year.
- Total Current Liabilities was $9.9 million for Q4 2025 at Medicus Pharma, down from $10.7 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $10.7 million in Q3 2025 and troughed at $781609.0 in Q4 2023.
- Average Total Current Liabilities over 3 years is $5.9 million, with a median of $5.9 million recorded in 2025.
- Year-over-year, Total Current Liabilities jumped 195.06% in 2024 and jumped 330.92% in 2025.
- Over 3 years, Total Current Liabilities stood at $781609.0 in 2023, then jumped by 195.06% to $2.3 million in 2024, then surged by 330.92% to $9.9 million in 2025.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $9.9 million in Q4 2025, $10.7 million in Q3 2025, and $8.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 36.63 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 57.72 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 42.10 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -32.57 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 26.95 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 24.96 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 9.48 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 34.35 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Medicus Pharma | 6.91 Mn | -1.69 Mn | - | 9.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.94 Mn |
| Sep 30, 2025 | 10.66 Mn |
| Jun 30, 2025 | 8.54 Mn |
| Mar 31, 2025 | 3.34 Mn |
| Dec 31, 2024 | 2.31 Mn |
| Dec 31, 2023 | 781,609.00 |